Suppr超能文献

儿童异位自律性房性心动过速:临床特征、治疗与随访

Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.

作者信息

Mehta A V, Sanchez G R, Sacks E J, Casta A, Dunn J M, Donner R M

机构信息

Pediatric Heart Institute, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania.

出版信息

J Am Coll Cardiol. 1988 Feb;11(2):379-85. doi: 10.1016/0735-1097(88)90106-4.

Abstract

Ectopic automatic atrial tachycardia, an uncommon type of supraventricular tachycardia in children and adults, has been reported to be resistant to medical therapy, and surgical or cryoblation has been recommended. This report describes 10 infants and children (median age 6 months; range birth to 7.5 years) with automatic atrial tachycardia and their management and follow-up. Digoxin alone was unsuccessful in controlling tachycardia in all 10 patients but decreased the tachycardia rate by 5 to 20% in 8. Intravenous (0.1 mg/kg body weight per dose) and oral propranolol successfully suppressed tachycardia in three of five patients and oral propranolol successfully controlled tachycardia in two of five other patients. Class I antiarrhythmic agents--quinidine (three patients), procainamide (four patients) and phenytoin (three patients)--did not control tachycardia in any patients but made the tachycardia rate worse in three patients. Intravenous (5 mg/kg per dose) and oral amiodarone suppressed tachycardia in three of four patients and oral amiodarone suppressed it in another patient. Thus, intravenous propranolol and amiodarone were effective in acutely suppressing automatic ectopic atrial tachycardia and predicted the response to long-term oral therapy. One patient had persistent tachycardia after surgical ablation of the high right atrial ectopic focus, and another patient had unsuccessful catheter ablation of the high right atrial ectopic focus (25 J). During follow-up (10 to 28 months), ectopic atrial tachycardia resolved completely in four patients and was well controlled in four patients.

摘要

异位自律性房性心动过速是儿童和成人中一种不常见的室上性心动过速类型,据报道对药物治疗有抵抗性,因此推荐采用手术或冷冻消融治疗。本报告描述了10例患有自律性房性心动过速的婴幼儿(中位年龄6个月;范围从出生至7.5岁)及其治疗和随访情况。单独使用地高辛未能成功控制所有10例患者的心动过速,但有8例患者的心动过速心率降低了5%至20%。静脉注射(每剂0.1 mg/kg体重)和口服普萘洛尔成功抑制了5例患者中3例的心动过速,口服普萘洛尔成功控制了另外5例患者中2例的心动过速。Ⅰ类抗心律失常药物——奎尼丁(3例患者)、普鲁卡因胺(4例患者)和苯妥英(3例患者)——均未能控制任何患者的心动过速,反而有3例患者的心动过速心率恶化。静脉注射(每剂5 mg/kg)和口服胺碘酮抑制了4例患者中3例的心动过速,口服胺碘酮在另1例患者中抑制了心动过速。因此,静脉注射普萘洛尔和胺碘酮可有效急性抑制异位自律性房性心动过速,并可预测长期口服治疗的反应。1例患者在手术消融高位右房异位灶后仍有持续性心动过速,另1例患者高位右房异位灶导管消融(25 J)未成功。在随访期间(10至28个月),4例患者的异位房性心动过速完全消失,4例患者的病情得到良好控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验